This Solicitation opportunity from Department Of Defense was posted on July 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

RINGER'S INJECTION, LAC

Closed

SPE2DP-26-T-4338Federal

Submission Closed08/03/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Bupivacaine Hydrochloride InjectionThis subcontract involves the supply of pharmaceutical-grade Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML (NSN: 6505001387347) to prime contractors supporting Department of Defense DLA Troop Support medical supply contracts. The agreement requires the delivery of 2,000 units within a strict five-day window, ensuring all products meet USP standards and possess a minimum shelf-life of 24 months. To maintain product integrity, the supplier must utilize climate-controlled logistics to keep the injections within a temperature range of 20 to 25 degrees Celsius. This procurement is managed under NAICS code 325412 through the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Simethicone Tablets (USP) SupplyThis subcontract involves the supply of Simethicone Tablets, USP, 80 MG, Chewable, for prime contractors delivering to the Department of Defense Medical Supply Chain Pharm FSA. The contractor is responsible for manufacturing or sourcing the tablets according to USP standards, ensuring they are produced in FDA-approved facilities. The product must be delivered in unit dose 100-count blister packs with a minimum shelf life of 36 months and must adhere to Medical Marking Standard No. 1. The contract is categorized under NAICS code 325412 and is associated with a performance location in Washington. Interested parties should note the response deadline of November 4, 2026, for this procurement effort.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Casualty Triage Tags (NSN 6515015871700)

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Loratadine Tablets 10 MGThis subcontract involves the supply of pharmaceutical-grade Loratadine 10 MG tablets, identified by NSN 6505-01-524-9179, to prime contractors supporting the Department of Defense Medical Supply Chain. The tablets must be packaged in bottles of 500 units and maintain a non-extendable shelf life of 36 months. To ensure product integrity, the contract mandates strict climate-controlled storage and transport conditions, requiring temperatures to be held between 20 to 25 degrees Celsius and protection from moisture. The performance of this contract is centered at Camp Pendleton, California. Interested parties must adhere to the timeline associated with the solicitation, which was posted on October 29, 2026, with a response deadline of November 4, 2026. The procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Hydrogen Peroxide Topical SolutionThis subcontract involves the supply of 50 bottles of 3% stabilized hydrogen peroxide topical solution, with each bottle containing 473ml, for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The products must strictly adhere to Medical Marking Standard No. 1 and be packaged according to MIL-STD-2073-1E and MPPWN00001. Delivery is required FOB Destination to Washington. Due to the nature of the product, the contractor must ensure full compliance with hazardous materials regulations, including 49 CFR, 29 CFR, ICAO, and IMDG standards. The opportunity is categorized under NAICS code 325412, with a response deadline set for November 4, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Sterile Surgical Lubricant (NSN 6505016265774)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-27-T-0204

Solicitation SPE2DP-27-T-0204 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 40 bottles of 1.4% artificial tears solution (NSN 6505009617486), each with a 15 ML capacity. The contract requires a non-extendable shelf life of 36 months and specifies delivery to the USS NITZE DDG 94. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 28, 2026. The terms are FOB Destination, and both inspection and acceptance will occur at the destination. The contractor must adhere to strict packaging and marking standards, primarily Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and sealed in suitable containers to prevent damage, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025 and labeled per the Hazard Communication Standard; otherwise, ASTM D3951 applies. Invoicing must be processed electronically through the Wide Area WorkFlow system. The award process includes a HUBZone price evaluation preference, and any offers utilizing additive manufacturing are ineligible for award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0202

This solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of six units of Permethrin Cream Rinse (NSN 6505-01-256-4972). The required product is a 1% W/V Permethrin active ingredient supplied in a 2 fl oz plastic squeeze bottle and must include a comb. The item is FDA-regulated and has a total shelf life of 24 months, with a mandatory minimum of 21 months remaining upon receipt by the government. Delivery is required within five days after receipt of order (ADO) to a destination in Poland. The contract mandates strict adherence to medical and hazardous material standards, requiring marking in accordance with Medical Marking Standard No. 1 and packaging per MIL-STD-2073-1E. Suppliers must provide Safety Data Sheets (SDS) and Hazardous Communication Standard labels prior to award, with a copy of the SDS accompanying each shipment. Invoicing must be processed through the Wide Area WorkFlow (WAWF) system. Key regulatory clauses include the Buy American Act, DFARS cybersecurity reporting requirements, and the prohibition of additive manufacturing processes for the provided items. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-27-T-0206

Solicitation SPE2DP-27-T-0206 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 50 bottles of Hydrogen Peroxide Topical Solution, USP. The product is an over-the-counter topical solution for external use containing 3% stabilized hydrogen peroxide, with each unit of issue consisting of a 473 milliliter bottle. Delivery is required within 20 days of award to a destination in Washington DC. The procurement is governed by NAICS code 325412 and requires compliance with the Buy American and Balance of Payments Program for quotes exceeding the micro-purchase threshold. The contractor must adhere to strict quality and safety standards, including FDA regulations and the DLA Master List of Technical and Quality Requirements. Packaging and marking must comply with MIL-STD-2073-1E, Medical Marking Standard No. 1, and Special Packaging Instructions MPPWN00001. Because the item is classified as hazardous material, the contractor must provide a current Material Safety Data Sheet (MSDS) and ensure all labeling and shipping comply with 49 CFR, ICAO, and IMDG regulations. Inspection and acceptance will occur at the destination per FAR 52.246-2. Invoicing and payment must be processed electronically through the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0207

Solicitation SPE2DP-27-T-0207 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Simethicone Tablets, USP, 80 mg, chewable. The required product is an FDA-regulated drug provided in unit dose 100-count blister packs. Key technical specifications include a non-extendable shelf life of 36 months for Type I (Code Q) items. The contract requires delivery to the DC ARNG Med Det in Washington, DC, with a delivery window of 20 days after receipt of order and a required delivery date of November 2, 2026. The contractor must adhere to strict packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging data per MIL-STD-2073-1E. Inspection and acceptance will occur at the destination. Administrative requirements include electronic invoicing via the Wide Area WorkFlow (WAWF) system and compliance with various FAR and DFARS clauses, including the Buy American Act and cybersecurity reporting under DFARS 252.204-7012. Quotations must be submitted via the DIBBS portal by November 4, 2026, and the submission of a Safety Data Sheet is mandatory for a responsibility determination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0208

Solicitation SPE2DP-27-T-0208, issued by DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Loratadine 10 mg tablets (NSN 6505-01-524-9179). The requirement is for two bottles, with each bottle containing 500 tablets. The items are FDA-regulated and must be stored between 20° to 25° C and protected from excessive moisture. The product is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order, with terms set as FOB Destination and performance located at Camp Pendleton, California. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPPWN00001. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The solicitation incorporates various federal regulations, including the Buy American Act, DFARS requirements for safeguarding covered defense information, and prohibitions on certain telecommunications equipment. Quotations are due by November 4, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE HYDROCHLOR

Solicitation # SPE2DP-27-T-0203

Solicitation SPE2DP-27-T-0203, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML. The requirement consists of two units under NSN 6505001387347, with a non-extendable shelf life of 24 months. The product is FDA-regulated and must be stored between 20 to 25 degrees Celsius. Delivery is required within five days of award, with an original required delivery date of October 30, 2026, shipped FOB Destination to the US Army SSA in Powidz, Poland. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical materials. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers compliant with MIL-STD-2073-1E and DLA packaging requirements for palletization. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment. The solicitation incorporates various FAR and DFARS clauses regarding hazardous material identification, cybersecurity reporting, and domestic origin preferences under the Buy American Act.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days

AI Contract Overview

RINGER'S INJECTION, LACTATED, USP, 1000ML in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4338 with a total quantity of 3 cases, each containing 12 units, for delivery to Bogalusa, LA within five days under FOB destination terms. The product must be packaged in sealed unit containers that protect against damage and shipped in commercial exterior containers suitable for safe transport by common carrier at the lowest cost, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item, manufactured by B. BROWN MEDICAL INC with NDC 00264-7750-00, has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C) with brief exposure up to 40°C permitted; freezing and excessive heat must be avoided. All packaging and labeling must adhere to the latest version of the Medical Marking Standard No. 1, available through DLA Troop Support, and technical and quality requirements referenced by R or I numbers are governed by the DLA Master List in effect at the solicitation or award date. The contract specifies zero variance in quantity, inspection and acceptance occur at delivery point, and government identification must be removed from non-accepted supplies. The FDA regulates this drug, requiring buyer referral via EBS to the product specialist, including manufacturer and bidder details. The purchase is under the DoD unit of issue system, and procurement falls under NAICS 325412.

General Info

Ringer’s Injection, Lactated, 1000ML, 36 units, FOB Bogalusa LA, B. BROWN MEDICAL INC, 30-month shelf life, room temperature, Medical Marking Standard No. 1.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

59406 HWY 10, BOGALUSA, LA, 70427-0000, USA

Set-Aside

NONE

Documents

RFQ SPE2DP-26-T-4338 Medical Supply Chain

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

1 update

PhaseClosed

PostedJul 28

Solicitation

Notice updatedJul 28

The notice description changed.

Response DeadlineAug 3

Deadline has passed

Submission Closed

08/03/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

Timothy Mccauley

contact@example.gov

+1 (555) 000-0000

Full Description

RINGER'S INJECTION,LACTATED
RINGER'S INJECTION LACTATED,USP, 1000ML, 12S
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product. RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 PG = 12 EA
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number,
SPE2DP-26-T-4338
SECTION B
and item description. RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
. SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
B. BRAUN MEDICAL INC 11171 P/N L7500 B. BRAUN MEDICAL INC 11171 P/N NDC00264-7750-00
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017631849 0001 PG 3.000
NSN/MATERIAL:6505013306267
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-330-6267 Quantity: 3 PG Purchase Request: 7017655814QTY: 5 Delivery: 5 days ADO